CRISPR Cas9 Gene-Editing Tech Leads new Parkinson's Disease Screening Tool
A team of researchers from Florida wants to develop a new screening tool for Parkinson's disease using the CRISPR Cas9 gene-editing technology, a crucial step to identifying new drug therapies for the degenerative disorder of the nervous system.